Back to search results

Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Cutaneous Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Moffitt Cancer Center, Tampa, Florida, United States

    Contact: Principal Investigator (Andrew Brohl, MD)
    Mihaela Druta, MD (Sub-investigator)
    Jonathan Metts, MD (Sub-investigator)
    Mauricio Silva Almeida Ribeiro, MD (Sub-investigator)
    Michael Shafique, MD (Sub-investigator)
    Leah Clark, ARNP (Sub-investigator)
    Isabel Canizares, RN, BAS, OCN (Sub-investigator)
    Sara McElroy, DPN, ARNP, FNP-BC, CPN (Sub-investigator)

  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

  • MD Anderson Cancer Center, Houston, Texas, United States

Study leads

  • Andrew Brohl, MD

    Principal Investigator

    Moffitt Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)